Acceptance rate of clinical study endpoints and adequacy of source documentation: experience from clinical study endpoint review in NEAT001/ANRS143

INTRODUCTION: NEAT001/ANRS143 was an open-label, randomized, non-inferiority study comparing raltegravir+darunavir/r(RGV+DRV/r) vs. tenofovir/emtricitabine+darunavir/r (TDF/FTC+DRV/r) in HIV-infected antiretroviral naïve adults. Primary efficacy outcome was a composite of virological and clinical ev...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Int AIDS Soc
Main Authors: Berenguer, Juan, Wit, Ferdinand, Jansson, Per O, Schwimmer, Christine, Kowalska, Justyna D, Saillard, Juliette, Diallo, Alpha, Pozniak, Anton L, Raffi, François, Grarup, Jesper
格式: Artigo
語言:Inglês
出版: International AIDS Society 2014
主題:
Poster Sessions – Abstract P040
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224823/
https://ncbi.nlm.nih.gov/pubmed/25394079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19572
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍